| Date Filed | Type | Description |
| 06/08/2023 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Bought 14,000 shares
@ $0.6931, valued at
$9.7k
|
|
| 06/07/2023 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Bought 26,000 shares
@ $0.6328, valued at
$16.5k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Bought 25,000 shares
@ $0.9405, valued at
$23.5k
|
|
| 01/26/2023 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Bought 25,000 shares
@ $0.873, valued at
$21.8k
|
|
| 01/23/2023 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Bought 25,000 shares
@ $0.7482, valued at
$18.7k
|
|
| 01/03/2023 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Bought 100,000 shares
@ $0.437, valued at
$43.7k
|
|
| 12/16/2022 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Granted 475,000 options to buy
@ $0.58, valued at
$275.5k
|
|
| 12/27/2021 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 650,000 options to buy
@ $0.3314, valued at
$215.4k
|
|
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2021 |
4
| SHALLCROSS STEVEN A (Director) has filed a Form 4 on Twin Vee PowerCats, Co.|
Txns:
| Granted 5,500 options
@ $5.8, valued at
$31.9k
|
|
| 07/20/2021 |
3
| SHALLCROSS STEVEN A (Director) has filed a Form 3 on Twin Vee PowerCats, Co. |
| 05/10/2021 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.4919, valued at
$24.6k
|
|
| 01/27/2021 |
4
| SHALLCROSS STEVEN A (Director) has filed a Form 4 on Elys Game Technology, Corp.|
Txns:
| Granted 5,245 shares
@ $5.72, valued at
$30k
|
|
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2019 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 450,000 options
@ $0.418, valued at
$188.1k
|
|
| 08/26/2019 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.4157, valued at
$20.8k
|
|
| 07/08/2019 |
4/A
| SHALLCROSS STEVEN A (Director) has filed a Form 4 on Newgioco Group, Inc.|
Txns:
| Granted 82,500 options
@ $0.37, valued at
$30.5k
|
|
| 07/08/2019 |
4
| SHALLCROSS STEVEN A (Director) has filed a Form 4 on Newgioco Group, Inc.|
Txns:
| Granted 2,500 options
@ $0.37, valued at
$925 |
|
| 06/18/2019 |
3
| SHALLCROSS STEVEN A (Director) has filed a Form 3 on Newgioco Group, Inc. |
| 12/07/2018 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 200,000 options
@ $0.6895, valued at
$137.9k
|
|
| 12/21/2017 |
4
| SHALLCROSS STEVEN A (Interim CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 550,000 options
@ $0.52, valued at
$286k
|
|
| 12/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |